Carl Witkin

Carl represents private equity sponsors and their portfolio companies on a wide array of transactional matters, including mergers, acquisitions, growth capital investments, joint ventures, equity financings, corporate restructurings and establishing incentive equity plans. Carl’s representations span a wide variety of industries, including technology, software, healthcare, energy, consumer products, food and beverage, life sciences, and financial services.

Since joining Goodwin, Carl’s representations have included the following:

• SunMed Group Holdings in its definitive agreement to acquire Avanos Medical, Inc. (NYSE: AVNS)’s Respiratory Health business
• Lovell Minnick Partners in its acquisition of Definiti, a national retirement services provider
• Nutrabolt in its strategic partnership with Keurig Dr Pepper Inc. (NASDAQ: KDP), in which KDP made a cash investment in Nutrabolt of $863 million
• Ivy Exec, a qualitative B2B research network, in its sale to InnovateMR, a portfolio company of CIVC partners

Prior to joining Goodwin, Carl was an associate in the New York office of Kirkland & Ellis LLP.